3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
40
NET
5
Endocrine
5
Thoracic
3
Head & Neck
3
Sarcoma
2
Gynecologic
2
Other neoplasm
1
Other
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Brain Neoplasms
1899
Glioblastoma
1791
Glioma
1126
Central Nervous System Neoplasms
599
Astrocytoma
593
Neuroblastoma
552
Gliosarcoma
465
Oligodendroglioma
363
Neoplasms
312
Breast Neoplasms
273
Medulloblastoma
272
Carcinoma, Non-Small-Cell Lung
225
Recurrence
198
Sarcoma
183
Neoplasm Metastasis
183
Melanoma
181
Meningioma
177
Ependymoma
174
Lung Neoplasms
156
Lymphoma
133
Osteosarcoma
126
Meningeal Carcinomatosis
126
Neurofibromatosis 1
114
Wilms Tumor
111
Ovarian Neoplasms
110
Diffuse Intrinsic Pontine Glioma
105
Precursor Cell Lymphoblastic Leukemia-Lymphoma
103
Rhabdomyosarcoma
100
Lymphoma, Non-Hodgkin
96
Burkitt Lymphoma
89
Interventions
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Colonic Diseases
×
CNS
×
Clear all
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts